E-cigarette use declines among high school students, FDA and CDC say

E-cigarette use declines among high school students, FDA and CDC say


Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store on June 23, 2022 in El Segundo, California. – Vaping company Juul Labs said Thursday it would appeal a decision by the US Food and Drug Administration ordering all its products off the market, a move the agency said was based on safety concerns. (Photo by Patrick T. FALLON / AFP) (Photo by PATRICK T. FALLON/AFP via Getty Images)

Patrick T. Fallon | Afp | Getty Images

E-cigarette usage among U.S. high school students has fallen as the government pursues aggressive action against companies selling illegal vape products that appeal to young people, federal health regulators said Thursday.

The findings, a part of the 2023 National Youth Tobacco Survey, showed that from 2022 to 2023 e-cigarette use among high school students declined to 10% from 14.1%, a drop representing about 580,000 fewer high schoolers.

The decline comes as overall tobacco smoking among this group hits an all-time low, according to the Food and Drug Administration and the Centers for Disease Control and Prevention. Current use of any tobacco product by high school students declined by an estimated 540,000 students, to 1.97 million in 2023 from 2.51 million in 2022.

“It’s encouraging to see this substantial decline in e-cigarette use among high schoolers within the past year, which is a win for public health,” Brian King, director of the FDA’s Center for Tobacco Products, said in a release.

E-cigarette usage has been the most commonly used tobacco product among both high school and middle school students for a decade. For middle schoolers, grades 6 to 8, there were no significant changes in e-cigarette use from 2022 to 2023. Still, for middle schoolers, there was an increase in current overall tobacco product use to 6.6% from 4.5%.

Curbing e-cigarette usage among the country’s youth has been a top priority for U.S. health regulators. In recent months, the issue has become more cumbersome as newer vaping devices flood the market from overseas and circumvent existing tobacco regulation. The biggest culprit, the Chinese brand Elf Bar, can still be found on shelves despite being banned by the FDA.

Among students currently using e-cigarettes, Elf Bar was the most commonly reported brand at 56.7%, followed by Esco Bars, Vuse, JUUL and Mr. Fog, the report found.

The report reiterated that youth use of tobacco products remains unsafe.

King said the agency has more work to do to crackdown as “bad actors place profit over the health of our nation’s youth.”

“The FDA remains concerned about youth tobacco product use, and we cannot and will not let our guard down on this issue,” King said. “The agency has an array of enforcement tools at our disposal, and we’re committed to using them as appropriate.”

Over the past year, the FDA said it has issued more than hundreds of warning letters to manufacturers, distributors and retailers of unauthorized e-cigarettes, including several distributors of Elf Bar.



Source

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Health

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 […]

Read More
Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval
Health

Eli Lilly’s obesity pill led to around 12% weight loss in closely watched late-stage trial, paving way for approval

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said the highest dose of its daily obesity pill helped patients lose almost 12% of their body weight, or roughly 27 pounds, at 72 weeks in […]

Read More
Eli Lilly earnings are coming Thursday. Here’s what top analysts expect
Health

Eli Lilly earnings are coming Thursday. Here’s what top analysts expect

Many on Wall Street expect that Novo Nordisk ‘s loss has been Eli Lilly ‘s gain, and this will be good news for the Zepbound maker’s second-quarter results. Novo Nordisk’s stock has cratered about 47% since the start of the year, as doubts emerged about the outlook for its GLP-1 drugs, Ozempic for diabetes and […]

Read More